What is HIFU?

High Intensity Focused Ultrasound (HIFU) ablates prostate tissue using targeted ultrasound energy while leaving surrounding tissue unharmed.

NO CUTTING | NO RADIATION | NO HORMONES

Patient Benefits

Reduced risk of incontinence

 

Reduced risk of erectile dysfunction

 

PRESERVATION OF EJACULATION

 

PRESERVATION OF PROSTATE TISSUE

 

Minimally invasive

 

Short procedure time

 

No overnight hospital stay

 

Quick recovery

 

RETURN TO WORK IN A COUPLE DAYS

 

Now eligible for Medicare reimbursement!

How Does it work?

Have you ever used a magnifying glass to burn a small hole in a leaf? The same principle is at work with HIFU!

Instead of sunlight as the energy source, HIFU utilizes sound. Instead of a magnifying glass, HIFU utilizes a transducer to direct and focus the energy.

With Sonablate® state-of-the-art technology, HIFU can be used to ablate (heat and destroy) targeted tissue in a procedure that is customized to each patient’s diagnosis and clinical needs.

Hear From A HIFU Surgeon & HIS PATIENT

Would You Like To Speak With A HIFU Specialist ?

Please let us know how to contact you with the form provided, and a clinical HIFU specialist will reach out to you within 3-5 business days.

Regulatory Statement

Sonablate® has 510(K) clearance in the U.S. and is indicated for the transrectal high intensity focused ultrasound (HIFU) ablation of prostatic tissue. Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

LOCATE A HIFU SURGEON IN YOUR AREA.

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

17 May 2018

CHARLOTTE, N.C., May 17, 2018 /PRNewswire/ -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, congratulates Naren Sanghvi on his receipt of The William...

10 April 2018

Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.